Rankings
▼
Calendar
INSM Q1 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$40M
+9.1% YoY
Gross Profit
$30M
75.5% margin
Operating Income
-$84M
-208.5% margin
Net Income
-$92M
-227.9% margin
EPS (Diluted)
$-0.89
QoQ Revenue Growth
-2.9%
Cash Flow
Operating Cash Flow
-$128M
Free Cash Flow
-$129M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$692M
Total Liabilities
$491M
Stockholders' Equity
$202M
Cash & Equivalents
$410M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$40M
$37M
+9.1%
Gross Profit
$30M
$28M
+6.9%
Operating Income
-$84M
-$60M
-38.9%
Net Income
-$92M
-$66M
-38.1%
← FY 2021
All Quarters
Q2 2021 →